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Abstract
Background: Our understanding of the biology of osteoblasts is important as they underpin bone remodelling,
fracture healing and processes such as osseointegration. Osteoblasts isolated from human humeral samples display
distinctive biological activity in vitro, which relates to the samples’ bone types (subchondral (S), trabecular (T),
cortical (C)). Our aim was to isolate primary osteoblast cultures from different bone types from the proximal femur
of a clinical population of dogs presented for total hip replacement and compare the behaviour of the osteoblasts
derived from different bone types, to identify a preferred bone type for isolation.
Results: No differences were found for osteoblast doubling time (median for S = 2.9, T = 3.1 and C = 2.71 days,
respectively; p = 0.33), final cell number (median for S = 54,849, T = 49,733, C = 61,390 cells/cm2; p = 0.34) or basal
tissue non-specific alkaline phosphatase (TNAP) activity (median for S = 0.02, T = 0.02, C = 0.03 U/min/mg protein; p
= 0.81) between bone types after 6 days of culture in basal media. There were no differences in mineralizing TNAP
activity (S = 0.02, T = 0.02, C = 0.03 U/min/mg protein, p = 0.84) or in mineralized area (S = 0.05, T = 0.04, C = 0.04%, p
= 0.92) among cells from different bone types.
Conclusions: There is no significant difference in mean doubling time, basal or mineralizing TNAP activity or
mineralized area in osteoblasts derived from subchondral, cortical, or trabecular bone types from the canine
femoral head. However, there appears to be a high level of inter-animal variability in the studied parameters, which
was independent of age, body mass, and sex. Trabecular isolate osteoblasts have the least variation of the bone
types studied, and therefore should be considered a preferred source for primary osteoblast cultures. The work here
provides baselines for canine osteoblast function, which has utility for future comparative studies.
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Background
Isolation of osteoblasts from adult human bone was first
undertaken in the 1970s [1]. A vast amount of in vitro
work has followed since and osteoblastic cell lines have
been used as models for understanding numerous char-
acteristics such as differentiation, cytokine and hormone
regulation, bone matrix synthesis and the molecular
mechanism of bone disease. More recently, osteoblast
cultures have been important in our understanding of
drug mechanisms, tissue engineering and the osseointe-
gration of bone with implants [2]. Osteoblast cultures
are also important for developing our understanding of
complex processes occurring in osteoarthritis [3].
Although bone is highly conserved in terms of its de-
velopment, remodelling and healing, it is clear that dif-
ferent regional bone types (trabecular, cortical, and
subchondral) respond differently to in vivo challenges
[4–6]. Variations in osteogenic potential have been dem-
onstrated between marrow and periosteal osteoblasts
from the same individual [7]. Such differences in bone
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type are however, often overlooked yet they remain im-
portant to consider. For example, trabecular bone, which
is mainly found within the metaphyseal regions and ex-
tremities of long bones, is architecturally distinct from
cortical and subchondral bone and usually provides
load-bearing support with a large area over which bone
(re)modelling occurs, potentially lending itself to higher
metabolic remodelling than cortical bone [8, 9]. There is
therefore, a need to consider whether the bone type that
osteoblasts are isolated from could influence their in
vitro characteristics. Work on human osteoblasts iso-
lated from cortical, subchondral and trabecular bone
types have shown significant variation in biological activ-
ity in vitro, and this effect was conserved across patients
with osteoarthritis or osteoporosis [10]. Briefly, osteo-
blasts from subchondral and cortical bone types prolifer-
ated more rapidly than those from trabecular bone, and
tissue non-specific alkaline phosphatase (TNAP) activity
was enriched in trabecular human osteoblasts. Could
this phenomenon be conserved across different joints
and species? If so, this may have implications for in vitro
primary osteoblast culture studies, in addition to clinical
considerations such as osseointegration of uncemented
hip replacements.
Canine bone biology is close to that of humans in
terms of structure and remodelling characteristics [11–
13]. There is also a developing understanding and appre-
ciation of dogs with spontaneous disease such as osteo-
sarcoma [14] and osteoarthritis [15]. The canine patient,
with its spontaneous development of osteoarthritis, is ar-
guably a more relevant model of human hip osteoarth-
ritis [16–18] than induced rodent models. Unlike
rodents, dogs are increasingly receiving hip replacements
for end-stage joint disease. To date there have been no
studies evaluating clinical samples of canine osteoblasts
taken from different bone tissue types, which may have
implications for implant research and development.
This study aimed to evaluate whether bone
type-specific differences in osteoblast growth and differ-
entiation activity exist within the canine proximal femur,
and if so, to determine which bone type may be most
appropriate for future in vitro osteoblast studies using
canine samples. Primary human osteoblasts display dis-
tinct in vitro behaviours that relate to the bone type
from which they were isolated, so we hypothesised that
there would be significant differences in canine osteo-
blast behaviour between different bone types.
Results
Canine samples
Samples were collected as clinical residue from 11 con-
secutive dogs undergoing elective total hip replacement
due to osteoarthritis. Seven males and four females were
enrolled, with a mean age of 6.1 ± 2.9 years and mean
weight of 30 ± 12 kg. Characteristics of each individual
sample are listed in Table 1. Breeds included: two Ger-
man shepherds, Labrador, Briard, Labradoodle, Italian
Spinone, West Highland Terrier, Golden Retriever, Re-
triever crossbreed, and two Border Collies. These are all
medium or large breeds and the only chondrodystrophic
breed (i.e. with inherited breed-associated cartilage mal-
formations) was the West Highland terrier. All dogs
were returned to their owners following recovery from
surgery; their clinical progress was not followed as part
of this study.
Canine bone cells from different bone types have no
differences in proliferation rates or basal TNAP activity
Canine osteoblasts derived from different bone types did
not show significant differences in proliferation rates or
basal TNAP activity. There were no statistical differ-
ences in doubling time or final cell number between os-
teoblasts from subchondral, trabecular or cortical bone
types after 6 days of culture in basal media (Fig. 1, p =
0.33 and p = 0.34, respectively). After 24 h of confluence,
cells were assessed for basal TNAP activity and there
was no difference in enzymatic activity between osteo-
blasts from subchondral, trabecular or cortical bone
types (Fig. 2 p = 0.81).
Canine bone cells from different bone types have no
differences in mineralizing ability or TNAP activity at
mineralization
We analysed both the mineralized area and the TNAP
activity of the canine osteoblasts after maintenance for
40 days in mineralizing media. We found no differences
in either TNAP activity (p = 0.84) or in the mineralized
area (p = 0.92, Fig. 3).
Individual dog characteristics do not explain variance in
the studied parameters
Individual dog characteristics (age, gender, body mass or
bone type) did not explain cell number, variance in basal
or mineralizing TNAP activity or in mineralized area. To
understand if the osteoblasts from subchondral, trabecu-
lar or cortical bone types exhibited cellular characteris-
tics that were influenced by dog size, age, gender or
bone type, a linear mixed model analysis was used to
identify the main effects and the results are summarized
in Table 2. None of the individual dog characteristics or
bone type significantly explained the variance observed
in cell number, mineralized area or basal and mineraliz-
ing TNAP activity.
Methods
Patients and sample preparation
Client-owned clinical veterinary patients undergoing
treatment for spontaneous hip osteoarthritis, diagnosed
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radiographically, and subsequently selected for total hip
replacement based on clinical and radiographic evalu-
ation were prospectively enrolled. Only skeletally mature
dogs that were greater than 10 kg in body mass (range
10–47 kg), with no known concurrent medical condi-
tions were included. Patient data that was recorded in-
cluded: age, weight, breed and concurrent medication
either related or unrelated to the hip osteoarthritis. All
dogs received perioperative intravenous cephalexin, 60–
120 min prior to sample acquisition. Aseptic surgical
technique was employed and a femoral head with
proximal neck ostectomy was performed by means of an
oscillating sagittal saw (Compact Air Drive II System,
DePuy Synthes). The resected tissue was aseptically
transferred from the operating theatre in sterile
phosphate-buffered saline (PBS) with 10%
antibiotic-antimycotic (AB/AM - penicillin, strepto-
mycin, amphotericin B; Invitrogen, Paisley, UK). Samples
were then kept at 4 °C for up to 24 h prior to processing.
Informed consent was obtained from the dogs’ owners
by means of a residual tissue clause in the client consent
form with appropriate institutional ethical review board
approval (URN 20181829–2).
Preparation of explants and subchondral, trabecular and
cortical bone primary osteoblasts
The excised femoral head was cut in the frontal plane
with an IsoMet® Low Speed Diamond Saw (Buehler,
Coventry, UK) to facilitate access to subchondral, tra-
becular, and cortical bone types. Subchondral bone was
prepared by removing the overlying cartilage with a scal-
pel and then isolated using rongeurs. Trabecular bone
was collected from the epiphysis avoiding the growth
plate area. Cortical bone was collected from the femoral
neck region. The pieces of bone from each type were cut
into 1 mm3 explants and vortexed separately, at least six
times in PBS (Gibco, Paisley, UK) containing 10% AB/
AM to remove bone marrow, blood and other debris.
The following isolation procedure was previously de-
scribed for human humeral samples [10, 19] and applied
Table 1 Sample characteristics
Canine sample Age (years) Sex Body mass (kg) Breed Medication
Dog 1 5.6 Male 39 German shepherd None
Dog 2 8.8 Female 33 Labrador NSAID
Dog 3 1.0 Female 30 Briard NSAID
Dog 4 7.0 Female 32 Labradoodle NSAID
Dog 5 6.9 Male 47 Italian Spinone NSAID
Dog 6 9.4 Male 10 West Highland Terrier None
Dog 7 4.3 Male 28 Golden retriever NSAID
Dog 8 2.3 Male 40 German shepherd NSAID
Dog 9 9.3 Male 42 Retriever crossbred NSAID
Dog 10 8.7 Female 13 Border collie NSAID
Dog 11 3.8 Male 19 Border collie NSAID
NSAID non steroidal anti-inflammatory drug
Fig. 1 After 6 days in basal media primary osteoblasts isolated from different bone types showed wide variation but no statistically significant
differences in median doubling time or final cell number. SC – subchondral, TRB – trabecular, C – cortical
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with some modifications. Briefly, the bone pieces were
incubated with 1% trypsin (Gibco, Paisley, UK) for 10
min at 37 °C. The trypsin was discarded and fragments
were then washed in Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco, Paisley, UK) and in PBS. Bone
pieces were incubated in 0.2% collagenase type II (Sig-
ma-Aldrich, Dorset, UK) for 30 min at 37 °C; the super-
natant was discarded and fragments were washed in PBS
and then in DMEM (low glucose, pyruvate, no glutam-
ine, no phenol red). The fragments were then seeded in
75 cm2 culture flasks (Nunc, UK) in DMEM
supplemented with 10% fetal calf serum (Invitrogen,
Paisley, UK), 2 mM L-glutamine (Invitrogen, Paisley,
UK), 100 U/mL AB/AM (Invitrogen, Paisley, UK) as a
basal media at 37 °C, 5% CO2. Cultures were left for 7
days without media change and thereafter, a half media
change was performed every 4 days until confluent. At
confluence, cells were trypsin-digested (Invitrogen, Pais-
ley, UK) and sub-seeded in six replicates in basal media
in 12 or 6-well plates (Nunc, UK) at 50000 cells/well,
and the media was changed twice a week. Cells from the
different bone types were seeded as described above and
Fig. 2 After 24 h of confluence there were no statistically significant differences in median basal TNAP activity between cells from different bone
types. No morphological differences were observed in cultured cells (magnification 10x). SC – subchondral, TRB – trabecular, C - cortical
Fig. 3 After 40 days in mineralising media primary osteoblasts isolated from different bone types showed no differences in TNAP activity or in the
percentage of mineralized area. SC – subchondral, TRB – trabecular, C – cortical
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maintained in basal media until confluence. At 24 h
post-confluence cells were changed into mineralizing
media which consists of basal media plus 2 mM
β-glycerophosphate (Sigma-Aldrich, Dorset, UK) and
200 μg/mL of ascorbate (Sigma-Aldrich, Dorset, UK).
Media was changed twice a week until day 40 after
confluence.
Cell number and viability
Crystal violet binding to DNA was used to calculate the
number of viable cells in culture, based on the principle
that dead cells are no longer attached to the cell culture
plastic. Briefly, cells from the different bone types were
seeded into 12-well plates at 50000 cells/well, with six
replicates per region, per dog sample. Cells were main-
tained in basal media for 6 days before assessing cell
number. At day six, cells were washed with PBS and
fixed with 4% paraformaldehyde (Sigma-Aldrich, Dorset,
UK). Cells were stained with 0.1% crystal violet (Sig-
ma-Aldrich, Dorset, UK) in distilled water for 30 min at
room temperature. Cells were subsequently washed with
distilled water to remove excess dye and the bound stain
was eluted from cells with 1mL of 10% acetic acid (Sig-
ma-Aldrich, Dorset, UK). The quantity of nuclear stain
was assessed by transferring 200 μL of the acetic acid so-
lution to a 96 flat well plate (Nunc, UK) and the absorb-
ance was measured at 595 nm in a Tecan M200 Pro
Plate Reader (Tecan Trading AG, Switzerland). A stand-
ard curve was prepared with known serial dilutions of
canine cells that were stained. Absorbance was used as a
direct measure of cell nucleus staining, and cell number
was extrapolated from the standard curve.
Tissue non-specific alkaline phosphatase (TNAP) activity
assay
Cell lysates were collected 24 h after confluence or, at
the same time, plates were fixed for analysis from each
individual well. In distilled water, cells were scraped off
the plate and the cell suspension was centrifuged. A
modified version of the SensoLyte® pNPP Alkaline Phos-
phatase Assay Kit (AnaSpec, Belgium) was used, where
50 μL of cell lysate supernatant was incubated with the
pNPP chromogenic liquid substrate and absorbance was
measured at 37 °C, 405 nm at regular intervals in a
Tecan M200 Pro Plate Reader (Tecan Trading AG,
Switzerland). The cell lysate was also used to measure
protein content with the Bradford reagent (Sigma-Al-
drich, Dorset, UK) according to the manufacturer’s
instructions.
Mineralization analysis
Cells which had been maintained in mineralizing media
in 6-well plates for 40 days were fixed and analysed using
the methods described previously [19]. Briefly, plates
were washed in PBS, fixed for 5 min at room
temperature with 2.5% Gluteraldeheyde (Sigma-Aldrich,
Dorset, UK) and then washed again with PBS and with
70% ethanol. When dry, plates were scanned at 2400
dots per inch (dpi) on a high-resolution flat-bed scanner
for analysis of mineralized nodule formation. ImageJ
(http://rsbweb.nih.gov/ij/) was used to determine the
surface area of mineralized bone nodules. Images were
binarized and subjected to automated analysis, using
constant threshold and minimum particle levels.
Statistical analysis
For each assay, six replicates of each culture were pooled
and the mean used for statistical purposes. D’Agostino--
Pearson tests were used to determine normality of distri-
butions. Kruskall-Wallis and Dunn’s post-hoc tests were
used to compare samples. Linear and non-linear regres-
sions were used to calculate correlations between cell
number and TNAP activity and to determine the contri-
bution of other sample characteristics such as age or
weight of dog. A linear mixed model was used to iden-
tify the relationship between sex, age, weight and bone
type (fixed factors) and the studied parameters (cell
number, basal and mineralizing TNAP activity and min-
eralized area). The model residuals were assessed for
normality. Fixed effects were evaluated individually first
before combining them in a multivariable model. Statis-
tical analysis was performed using GraphPad Prism 7.01
for Windows (GraphPad Software, La Jolla, CA, USA)
and IBM-SPSS version 22 (IBM, USA). P-values under
0.05 were considered significant. We assumed a TNAP
activity effect level from previous work [10] and calcu-
lated that six samples would be required in order to
achieve a power of 80% at the 5% significance level.
Table 2 Individual canine characteristics do not explain variation in cell number, TNAP activity or nodule formation. Fixed effects
were used in all cases. p-values are shown
Variable Cell number Basal TNAP activity TNAP activity at mineralization Mineralized area
Sex 0.445 0.271 0.613 0.116
Age (years) 0.340 0.391 0.787 0.471
Body mass (kg) 0.266 0.166 0.292 0.536
Bone site 0.116 0.448 0.717 0.877
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Discussion
Isolated canine osteoblasts, from all bone types showed a
wide variation in activity between individual dogs. This is
the first time that clinical patients have been the source of
bone tissue for osteoblast isolation, and may indicate that
although there are highly desirable aspects in looking to-
wards spontaneous disease models to develop our under-
standing, there is increased ‘noise’ or variation present
than in experimental models. Focussing on a single breed
or group of dogs may also reduce the variation seen but
could reduce the relevance to the dog population at large.
Nonetheless, osteoblast-like cells were successfully iso-
lated and trabecular-sourced osteoblasts had the least vari-
ation between individuals and may be a preferred
osteoblasts source for future studies.
Cells isolated by explant outgrowth will be heteroge-
neous; early osteoblasts will likely predominate, with ac-
celerated maturation in response to the supplemented
factors, such as glucocorticoids, vitamin D, or other
growth factors. The application of identical cell isolation
protocols to different samples can yield osteoblast cultures
that vary in terms of whether early or mature osteoblasts
predominate [10, 19, 20]. It is possible that despite using
identical cell isolation methods here as used previously,
that the variety of breeds, ages and body weights led to di-
vergence in specific osteoblast populations derived from
each bone type in each dog. We detected substantial
inter-animal variation in the studied parameters (doubling
time, TNAP activity - basal or mineralizing, and
mineralization), however, the variation was not directly re-
lated to dog size, age or sex. We observed smaller differ-
ences in parameter means than found previously in
human humeri [10] and therefore the size of our cohort
may not have been large enough to detect a smaller effect
size within the greater noise of individual variation. To ob-
serve a 20% effect size based on power 0.8 and significance
of 0.05, in our studied parameters within the variation we
measured, we would have to increase our cohort to 100
dogs. Another option to minimise the background differ-
ences between bone sites would be to use larger groups of
animals (6–10) from the same breed. Our findings suggest
that there is greater diversity among dogs’ osteoblast be-
havior than among human osteoblast behaviour, poten-
tially exacerbated by breed. Therefore, care needs to be
taken when making generalizations based on canine
osteoblast explants from clinical cohorts with spontaneous
orthopaedic disease. Whether or how the presence of hip
osteoarthritis influenced osteoblast behaviour diversity
also remains unclear, however, all samples were osteoarth-
ritic. Although non-diseased samples may have shown
site-specific differences in activity, non-diseased hip tissue
is difficult to obtain. The options include experimental an-
imals, non-repairable hip fractures treated with ostectomy
or cadaveric samples. It was not the intention of this one
medicine orientated study to use experimental animals,
and hip fractures/luxations are best primarily repaired
where possible and hence samples are rare. Cadaveric
samples are also problematic for cell viability and infec-
tion. Importantly, the differences seen in the human study
[10] were shown in diseased samples and hence diseased
canine samples were felt to be appropriate. It is important
to note however, that this paper cannot make direct com-
parisons with the human study in terms of cellular activity
(TNAP, cellular activity) as the cells were isolated from
different anatomical sites and used similar but not identi-
cal cell culture methods.
In contrast to human bone type osteoblasts isolated
from the humeral head, osteoblasts derived from the ca-
nine proximal femur exhibit a conserved, programmed
difference in bone type-related cell in vitro behaviour. A
lack of conservation of bone type-related behaviour from
the canine femur to the human humerus could poten-
tially be explained by one of a range of mechanisms such
as effect of load, variations in bone turnover between
bone sites (humerus vs femur), different species and ef-
fect of disease on cell culture characteristics. The loca-
tion from which bone is sampled and its individual
loading environment may explain the lack of
pre-programmed bone type-related behaviour seen in
the canine femur compared with the human humeral
head [10]. Mechanical load can drive bone adaptation in
structure, through the proposed actions of
mechano-sensitive osteocytes that produce signalling
molecules, such as NO, which in turn affect recruitment,
activity and differentiation of osteoclasts and osteoblasts
[21–26]. The human osteoblasts against which we com-
pare our results were isolated from the humeral head.
Due to humans’ bipedal gait osteoblasts in the humeral
head are subject to net muscular forces without add-
itional ground reaction forces, unlike the weight-bearing
hip joint [9, 27]. Studies have shown that shoulder joint
loading is 50–90% of body weight during abduction [28,
29], whereas the canine hip is at least one times body
weight [30, 31]. Therefore, a reduced loading scenario in
the shoulder as compared with the hip joint could influ-
ence the anabolic response of bone cells to those differ-
ing loads and hence the bone-type related behavioural
pattern may be abolished in the canine hip samples. Fur-
ther studies should address bone type-specific osteoblast
activity in the human proximal femur.
This study used clinical veterinary patients with spon-
taneous hip osteoarthritis. Species differences in osteo-
blast biology are well established, so it remains to be
established whether these current results could necessar-
ily be extrapolated to humans [2, 19]. Currently, there is
little information available as to how closely the veterin-
ary clinical disease resembles human hip osteoarthritis,
however, in terms of size, lifestyle, longevity, disease
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development, and treatment options, the dog is certainly
closer to human than the rodent. In terms of bone struc-
ture, the dog remains the closest non-primate animal
species to humans, however, clear differences in the rate
at which bone remodelling occurs, with dogs having a
significantly higher turnover rate than humans [32].
Additionally, quantitative histology of trabecular bone
has shown variable rates of turnover between different
locations such as lumbar compared with talar trabecular
compartments, being 200 and 12% per annum, respect-
ively. A further reason for selecting the canine femur
was the biology of osteoblast type in this location could
have translational impact on osseointegration of hip re-
placement prostheses, and a clinical source of these nat-
urally osteoarthritic samples was available. Future work
to determine the influence of bone-type on osteoblast
behavior would require further comparison between
samples derived from the human femoral head and or
canine humeral head.
Conclusion
There is a large individual variability between dogs in in-
herent biological activity of osteoblasts, independent of
their type; trabecular, cortical and subchondral. How-
ever, the trabecular bone type osteoblasts had the least
variation and should be considered the preferred source
of osteoblasts for in vitro studies. The work in this study
also provides a methodology for research groups looking
to isolate and expand canine osteoblasts, as well as pro-
viding baseline data for future explant studies from ca-
nine donors. This is important in context of ‘one
medicine’, whereby large animals with spontaneous nat-
ural disease are increasingly proposed as a missing link
between rodent research and human clinical translation.
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